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The induction of antigen-specific primary cytotoxic T  lymphocyte (CTL) responses 
in vitro clearly requires interactions between several cell types and soluble mediators 
(1-5). One essential  interaction occurs between the Lyt-2  + CTL precursor  (CTL-P) 
and an antigen-activated Lyt-1  + helper T  cell (6-8). This interaction is considered to 
occur by way of soluble mediator such as interleukin 2 (IL-2), a lymphokine produced 
by antigen-triggered helper cells that binds to IL-2 receptors expressed on CTL-P as 
a sequel to their preactivation by antigen or mitogen (9,  10). The expression of IL-2 
receptors probably occurs as antigen- or mitogen-triggered CTL-P move from Go to 
G1 in the cell cycle (11).  Further progress through the cell cycle, then, only occurs if 
IL-2 is present.  However, whereas  IL-2 may indeed  drive an  antigen-  or mitogen- 
preactivated CTL-P into proliferation, it is not clear whether IL-2 is also the stimulus 
that  causes  the  CTL-P  to  differentiate  into  effector CTL.  This  uncertainty  exists 
because  the  source  of IL-2  used  by  most  investigators  to  study  its  role  in  CTL 
induction  comes from concanavalin A  (Con A)  supernatants,  which  contains other 
biologically active molecules as well. We realized that IL-2 alone may not be sufficient 
to mature cells into CTL in preliminary experiments in which certain sources of IL-2 
were shown capable of driving Con A-preactivated Lyt-2  + cells to proliferation  but 
not differentiation into CTL (12).  However, as we show in this communication, IL-2 
preparations unable to cause CTL differentiation can be reconstituted with Con  A 
supernatants  that have been selectively depleted of their IL-2 content.  As such, our 
results  are  the  first  to  provide  evidence  for  the  existence  of  a  cytotoxic  T  cell 
differentiation  factor  (CTDF)  that  functions  to  convert  IL-2-driven  proliferating 
CTL-P into CTL. 
Materials and Methods 
Mice.  CBA/Ca  (H-2  k)  mice were obtained  from  OLAC  Ltd.,  Shaw's  Farm,  Blackthorn, 
England. 
IL-2-producing TLymphoma Cells.  The IL-2-producing EI~ variant  (13)  was kindly provided 
by Dr.  Farrar  (National  Institutes  of Health).  The IL-2-producing,  radiation-induced  T  cell 
lymphoma LBRM-33 (14)  was a  kind gift of Dr. G. Cudkowiez, Buffalo, N. Y. 
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Preparation of IL-2 Batches.  To produce LBRM-33 cell-derived IL-2, LBRM cells were grown 
in culture medium  (a 50% vot/vol mixture of Click's and  RPMI  1640  media supplemented 
with 10 mM Hepes, fresh glutamine, 5 ×  10  -5 M  2-mercaptoethanol, and 5% fetal calf serum 
(FCS)) and were washed and replated in serum-free medium containing 1% phytohemagglu- 
tinin (PHA-M) (Gibco Laboratories, Grand Island Biological Co., Grand Island, NY) for 6 h. 
After exchanging PHA-containing medium with normal medium, the cells were incubated for 
an  additional 24  h,  and  the supernatant  was recovered. EI_~-derived IL-2 was produced by 
seeding cells in serum-free medium (density of 1 ×  10S/ml) and stimulating for 36 h  with  10 
ng/ml phorbyl myristic acetate (Sigma Inc., Munich, Federal Republic of Germany [FRG]). 
IL-2 from CBA mouse spleen cells (107 eells/ml) was produced under serum-free conditions by 
stimulating with  1 btg/ml Con A  (Pharmaeia Fine Chemicals, Uppsala, Sweden)  for 24 h  as 
described previously (6). The supernatants were harvested and are termed "crude supernatant." 
Semipurification oflL-2.  The various culture supernatants were concentrated by ultrafiltration 
with an Amicon YM-10 membrane (Amicon Corp., Scientific Sys. Div., Lexington, MA) and 
subjected to fractionated (NH4)2SO4 precipitation. Proteins precipitating between 40 and 80% 
(NH4)2SO4 saturation were dialyzed against 0.02 M  phosphate-buffered saline (PBS) (pH 7.4), 
concentrated, and applied to a previously calibrated Sephadex G-100 column. Effluent fractions 
were tested for IL-2 activity. 
Assay for IL-2 Activity.  IL-2 was assayed by its ability to sustain in vitro growth of C1-3 cells, 
k  d  a cloned continuous IL-2-dependent line of H-2  anti-H-2  CTL kindly provided by Dr. Th. 
Hfinig, Institut flir Virologic, Wiirzburg, FRG. In brief, the CI-3 cells were washed free of 
growth  medium and  were seeded at 4  ×  10a/100/~1  into flat-bottomed 96-well microplates 
(Greiner GmbH, Niirtingen, FRG). After the addition of test samples of IL-2, cultures were 
incubated at 37°C for 24 h, and pulsed for 4 h  with 0.5/~Ci of [aH]thymidine (TdR)  (NEN 
Chemicals, Dreieich, FRG) as described (6). 
Selective Depletion of IL-2from Crude Supernatant.  IL-2-addicted CI-3 cells were washed free of 
growth medium and incubated in fresh medium for an additional 2 h at 37°C. Thrice-washed 
cells (30 ×  106) were resuspended in 3 mt of crude supernatant at 4°C for 30 min, pelleted, and 
incubated at 37°C for 2 h  in fresh medium to allow for shedding of receptor-bound IL-2 (M. 
Rfllinghoff, unpublished observations). The cells were reused for absorption five more times, 
after which the crude supernatant was tested for remaining IL-2 activity. 
Preparation of Lyt-1-2,3 + Cells Depleted  for Macrophages.  Splenic lymphocytes from 4-6-wk-old 
CBA mice were passed over nylon wool to enrich for T  lymphocytes and then over Sephadex 
G-10 to further deplete for adherent cells. Subsequently,  10  cells were treated with a  1:200 
dilution  of a  monoelonal  anti  Lyt-l.1  antibody  (NEN  Chemicals)  and  a  nontoxic  rabbit 
complement diluted 1:12. Dead cells were removed by centrifugation over Ficol]. Applying the 
indirect immunofluorescence technique with the appropriate Lyt antisera, virtually all viable 
T  cells proved to express the Lyt-1-2,3  + phenotye. 
Polyclonal Activation of CTL-P.  Replicates of Lyt-l-2,3  + T  responder cells (106) were seeded 
into flat-bottomed 96-wetl microplates in 200 #1 medium containing 2.5/zg Con A/ml plus the 
lymphokine batch indicated. The proliferative response was assayed by pulsing cultures after 
42 h for 6 h with 0.5/zCi aH[TdR]. The polyclonal induction of CTL was measured in a lectin- 
mediated universal readout (15), and cells of four microeultures were pooled, washed once, and 
resuspended in  1 ml. Graded numbers of viable cells were incubated with a constant number 
(2 ×  106) SlCr-labeled P815 tumor cells in the presence of 10/xg/ml PHA-P (Gibco Laboratories). 
Percent specific lysis was calculated as detailed previously (6). 
Preparation of Macrophage Culture Supernatant Rich in IL-I.  Thioglyeolate-induced peritoneal 
macrophages  (4  ×  10/ml)  were plated in  2 ml culture medium containing 0.5%  FCS and 
incubated with 5/.tg/ml lipopolysaccharide (Difco Laboratories, Detroit, Michigan) for 24 h. 
The culture supernatants were harvested and dialyzed against culture medium. These super- 
natants, which lacked detectable IL-2 activity, were rich in IL-1 activity as assayed by their 
ability to replace macrophages required for the Con A-induced production of IL-2 from purified 
T  cells (9). The activity of IL-1 was compared with a standard preparation arbitrarily set as 
100 U/ml (16).  The IL-1 preparation used contained 250 U. 
Results and  Discussion 
To evaluate our notion that IL-2 alone is not sufficient to cause the differentiation 1878  WAGNER  ET AL.  BRIEF  DEFINITIVE REPORT 
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Fro.  1.  Left:  comparison of the IL-2 activity of various lymphokines. In preliminary experiments, 
the IL-2 activity of the lymphokine batches used were adjusted to comparable levels. Thereafter, 
the II,-2 activity of crude supernatant  (O), semipurified IL-2 from the crude supernatant  (I), from 
EL4 tumor cells (0),  and from RBRM  tumor cells (A) were titrated  on IL-2-addicted CI-3 cells. 
Right: lack of IL-2 activity within crude supernatant  after repeated absorption with II-2-addicted 
CI-3 cells. 
of primary CTL in vitro, our experimental  protocol included the following rationale. 
First,  it was essential  to avoid interference  by regulatory Lyt-1 + T  ceils during CTL 
induction  because  such  cells  would  provide  IL-2  as  well  as  other  putative  helper 
factors endogeneously. To this end, negatively selected, macrophage-depleted  Lyt-2  + 
cells were used as the responder population.  Second, we needed to produce a  source 
of factor that retained differentiation activity but lacked demonstrable IL-2. This was 
achieved  using  an  IL-2-addicted  cell  line  to  absorb  out  IL-2  from  crude  Con  A- 
activated  supernatants.  As  shown  in  Fig.  1  (right  panel),  absorption  of Con  A 
supernatants  five times with CI-3 cells completely removed IL-2, as measured  by its 
ability to cause proliferation of C1-3 cells. That this factor still had CTDF activity is 
described subsequently. 
Four  sources  of IL-2 were  investigated  for their  ability  to cause  proliferation  of 
Lyt-2  + T  cells as well their differentiation  into CTL. As shown in Fig.  1 (left panel), 
the  four  factors  EL4,  LBRM,  crude  Con  A  supernatant,  and  semipurified  Con  A 
supernatant exhibited comparable IL-2 activity, as measured by their ability to cause 
proliferation of the IL-2-addicted cell line C1-3.  In addition,  as shown in Table I, all 
factors caused Con A  preactivated  Lyt-2  + T  cells  to proliferate  to a  similar  extent. 
However,  in contrast  to their  comparable  proliferation  activities  (i.e.,  IL-2), it  was 
only the crude Con A supernatant that caused the induction of high levels of cytolytic 
activity  (Fig.  2 A).  These  data  indicate  that  IL-2-driven  proliferation  (growth)  of 
preactivated Lyt-2  + cells does not necessarily result in CTL generation.  Furthermore, 
they infer that  a  second activity present  in crude supernatants  causes  proliferating 
CTL-P to differentiate into CTL. 
Further  evidence  for  this  notion  was  obtained  in  experiments  in  which  Con  A 
supernatants depleted of IL-2 by absorption with clone 3 cells and lacking proliferation 
activity (Fig. 1 B) were shown able to cause CTL induction (Fig. 2 A, B, C). However, 
far more striking was the observation that the IL-2-depleted Con A supernatant could 
restore the CTL-inducing activity of those sources of IL-2 that alone caused only Con 
A-preactivated  CTL-P to proliferate  (Fig.  2 A, B, C).  In these  combination experi- 
ments strong cytolytic responses were induced. 
Taken  together  our  results  lead  us  to  conclude  that  the  role  of IL-2  in  CTL 
induction is to cause the clonal expansion of those CTL-P that have been preactivated WAGNER  ET  AL.  BRIEF  DEFINITIVE REPORT  1879 
TAm.E  I 
Prol{~erative Responses of Con A-preaclivated Lyl-l-2,3 + T Responder Cells 
in the Presence of lL-2 and CTDF 
,+r  L,rt-1  2,3  F  es))ld  rcell~plusConA 
Lymphokines added 
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FIG. 2.  Crude Con A supernatant depleted  for IL-2 contains CTDF. Macrophage-depleted Lyt- 
1-2,3  +  responder T  cells  were cultured  for 48  h  in  the  presence of 0.5  btg/mt  Con  A  plus the 
lymphokine batches indicated below. Thereafter the lytic activity induced was tested in the presence 
of PHA (18) towards P815  target cells. The background lysis of P815  target celt during the 4-h assay 
time did not exceed 22%. (A) A,  10%  (voI/vol) IL-2 semipurified from crude supernatant; 0,  10% 
(vol/vol) crude supernatant; O,  10%  (vol/vol) IL-2-depleted (absorbed) crude supernatant; @, 5% 
(vol/vot) of 1  : 1 mixture ofIL-2 semipurified crude supernatant and IL-2-depleted crude supernatant. 
(B)  A,  10%  (vol/vol)  LBRM-derived  semipurified  IL-2;  O,  10%  (vol/vol)  IL-2-depleted  crude 
supernatant; @, 5% (vol/vol) of 1:1  mixture of both. (C)/X, 10% (vol/vol) EL-derlved semipurified 
IL-2;  O,  10%  (vol/vol)  IL-2-depleted  crude  supernatant;  @,  5%  (vol/vol)  of  1:1  mixture  of 
both; (~, 5% (vol/vol) of 1:1  mixture of EL4-derived  semlpurified IL-2 plus IL-1  (see Materials and 
Methods). 
by antigen or mitogen. However, such proliferating CTL-P do not differentiate into 
cytolytic effector cells.  For this to occur,  they must be stimulated  by a  second factor, 
distinct  from IL-2,  termed here CTDF. 
Although our data implicate  the Lyt-2 + cell  as the cell  that  responds  to CTDF,  at 
this stage we can only speculate  as to the nafure of the cell that  produces  the factor. 
Presumably  it  is  not  the  Lyt-2 +  cell  itself,  since  such  cells,  driven  to  proliferate  by 
IL-2,  fail to differentiate  into CTL. The data depicted  in Fig.  2 C  also argue against 1880  WAGNER ET AL.  BRIEF  DEFINITIVE REPORT 
the macrophage as the producer cell, because the supernatants  of activated macro- 
phage were devoid of CTDF activity. Because these supernatants were rich in IL-1, 
these  data  also serve to indicate  that  IL-t  is  not  the differentiation  factor.  Clearly 
further investigations are necessary to define the origin of CTDF and its relationship 
to other known lymphokines (17, 18). We do not favor the idea that CTDF is identical 
to )' interferon  (IF), because  Lyt-2  ÷ cytotoxic T  cells themselves produce ),-IF and 
should therefore be expected to provide the differentiation signal endogenously (19). 
Biochemical and functional  investigations are required  before a  clearer picture will 
emerge. 
The  dissection  of  proliferative  and  differentiative  signals  controlling  cytolytic 
responses of CTL-P in  a  lectin-mediated  universal  readout  resembles that  recently 
observed for IgM responses in unprimed B  cells (20,  21).  Could it be that the rules 
governing growth and  differentiation of effector cells of both the T  cell and  B  cell 
lineage parallel each other? 
Summary 
Evidence  is  presented  that  interleukin  2  (IL-2)  is  not  sufficient  to  cause  the 
differentiation  of primary  cytotoxic  T  lymphocytes  (CTL).  Sources  of IL-2  were 
compared for their ability to cause proliferation as well as differentiation into CTL, 
Whereas  all  factors  caused  proliferation,  only  the  crude  Con  A  supernatant  had 
cytotoxic T  cell differentiation factor (CTDF) activity. Furthermore, factors abmorbed 
with an IL-2-dependent cell line to remove IL-2 still retained CTDF activity, Thus~ 
IL-2 functions to cause clonal expansion of CTL precursors preaetivated by antigen 
or mitogen, but  for their differentiation  into CTL, an additional  factor is required, 
here called CTDF. 
Received  for publication 2 February 1982 and in revised  form 29 March  1982. 
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